Presolicitation
Ibandronate Sodium Presolicitation
Dept of Defense · Defense Logistics Agency · Sol. SPE2D2-20-R-0074
No deadline
AI summary Beta
The Defense Logistics Agency plans to issue a solicitation for a national requirements contract for Ibandronate Sodium 150MG tablets in 3-count bottles. Customers include DoD, VA, Indian Health Service and Bureau of Prisons through prime vendor programs. It is a one-year base plus four option years.
Watch out for
- Pharmaceutical product. This is a drug supply contract, so a small business would likely need to be an FDA-compliant manufacturer or supplier; the notice does not list specific requirements.
- Old notice. The notice was posted in 2020 with a projected solicitation date of September 2020, so it may be outdated.
The current projected solicitation date is September of 2020.
Read from the notice text only.
Full brief
What they want
- Ibandronate Sodium 150MG tablets in 3 count bottles
- Supply as a national source for DoD, VA, Indian Health Service and Bureau of Prisons customers
- Contract type
- Firm-fixed-price requirements contract (FAR 52.216-21), commercial item under FAR Part 12
- Period of performance
- One year base plus four one-year options
- Contract vehicle
- DLA and VA prime vendor programs (customers buy through them)
- How to submit
- Solicitation to be posted to DLA Bid Board System (DIBBS) and SAM.gov
What to include when you submit
- Set up automated notifications for pre-solicitation or solicitation changes
- Projected solicitation date was September 2020; DLA may issue before or after
You must have
- None restricted: unrestricted, fully competitive acquisition
This will be an unrestricted and fully competitive acquisition.
Not in the notice text
- Annual usage estimates (to be in the Schedule of Supplies in the solicitation)
- Proposal due date
- Evaluation factors
- Specific regulatory or FDA requirements
Is this a fit for your business?
Create a free accountFedReady checks notices like this against your business profile, tracks deadlines, and alerts you to new matches. Creating an account is free.
Key facts
- Posted
- Aug 25, 2020
- Notice type
- Presolicitation
- Solicitation
- SPE2D2-20-R-0074
- Agency
- Dept of Defense · Defense Logistics Agency
- Office
- DLA Troop Support
- NAICS
- 325412
- Product/service code
- 6505
- Business type
- Medical & healthcare
- Contracting contact
- Kevin Raffertykevin.rafferty@dla.mil2157370907
Full notice text from SAM.gov
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ibandronate Sodium Tablets. Procurement details follow. Ibandronate Sodium 150MG tablets in 3 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Beta Sam.Gov at https://beta.sam.gov/. Interested parties should contact Kevin Rafferty (215-737-0907) (kevin.rafferty@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is September of 2020. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Similar open opportunities
- Latanoprost Ophthalmic Solution (VA-27-00006027)The VA Enterprise Procurement Office plans an unrestricted RFP for Latanoprost eye drops for the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health Care Center.
- Imatinib TabletsThe VA Enterprise Procurement Office plans an unrestricted RFP for Imatinib Mesylate tablets to supply the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health…
- Methylphenidate ERThe Defense Logistics Agency (DLA Troop Support) plans a national requirements contract for Methylphenidate ER tablets (18, 27, 36 and 54 mg, 100-count bottles).
- Epinephrine InjectorThe Defense Logistics Agency (DLA Troop Support) is soliciting a national requirements contract for epinephrine 0.3 mg auto-injectors, to supply Department of Defense, VA, Indian…
- Prednisolone 1% Ophthalmic Solution